Intravitreal Aflibercept reduces the retinal vessel diameter in patients with diabetic macular edema

被引:0
|
作者
Consigli, Andrea [1 ]
Papanastasiou, Athanasios [1 ]
Roy, Sayon [2 ,3 ]
Thumann, Gabriele
Chronopoulos, Argyrios [1 ]
机构
[1] Univ Hosp & Sch Med, Dept Ophthalmol, Geneva, Switzerland
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[3] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2118
引用
收藏
页数:2
相关论文
共 50 条
  • [41] INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study
    de Andrade, Gabriel Costa
    de Oliveira Dias, Joao Rafael
    Maia, Andre
    Farah, Michel Eid
    Meyer, Carsten H.
    Rodrigues, Eduardo Buchele
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (09): : 1640 - 1645
  • [42] Efficacy of the combination of intravitreal aflibercept and triamcinolone injections in treatment of diabetic macular edema
    Liu, Yiwen
    Liu, Lan
    Chen, Peng
    Zhao, Yue
    Liang, Pengcheng
    Wang, Xi
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (12) : 2497 - 2504
  • [43] Multiple Effects of Intravitreal Aflibercept on Microvascular Regression in Eyes with Diabetic Macular Edema
    Sugimoto, Masahiko
    Ichio, Atushi
    Mochida, Daiki
    Tenma, Yumiho
    Miyata, Ryohei
    Matsubara, Hisashi
    Kondo, Mineo
    [J]. OPHTHALMOLOGY RETINA, 2019, 3 (12): : 1067 - 1075
  • [44] Efficacy and tolerance of Aflibercept intravitreal injection in vitrectomized eyes with diabetic macular edema
    Erginay, Ali
    Baillif, Stephanie
    Fourmiaux, Eric
    Lerouic, Jean Francois
    Uzzan, Joel
    Milazzo, Solange
    Kodjikian, Laurent
    Thi Ha Chau Tran
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab and/or intravitreal dexamethasone implant
    Herbaut, Antoine
    Knafo, Lise Qu
    Auregan, Audrey Giocanti
    Fajnkuchen, Franck
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [46] Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
    Herbaut, Antoine
    Fajnkuchen, Franck
    Qu-Knafo, Lise
    Nghiem-Buffet, Sylvia
    Bodaghi, Bahram
    Giocanti-Auregan, Audrey
    [J]. JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [47] Progression of diabetic macular edema: Correlation with blood-retinal barrier permeability, retinal thickness, and retinal vessel diameter
    Sander, Birgit
    Thornit, Dorte Nellemann
    Colmorn, Lotte
    Strom, Charlotte
    Girach, Aniz
    Hubbard, Larry D.
    Lund-Andersen, Henrik
    Larsen, Michael
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (09) : 3983 - 3987
  • [48] Retinal arteriolar oxygen saturation predicts the need for intravitreal aflibercept in patients with diabetic macular oedema
    Blindbaek, Soren Leer
    Peto, Tunde
    Grauslund, Jakob
    [J]. BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
  • [49] Three year outcomes of intravitreal ranibizumab and aflibercept treatment of patients with diabetic macular edema: A comparative study
    Akbas, Yusuf Berk
    Alagoz, Cengiz
    Cakmak, Semih
    Demir, Gokhan
    Alagoz, Nese
    Artunay, Halil Ozgur
    [J]. THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2023, 15
  • [50] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion
    Giuffre, Chiara
    Cicinelli, Maria Vittoria
    Marchese, Alessandro
    Coppola, Michele
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (04) : 787 - 793